Wealthy countries already have agreements for 3.73bn doses, with another 5m under negotiation, study finds
- Coronavirus – latest updates
- See all our coronavirus coverage
Governments in predominantly wealthy countries are negotiating to buy nearly 8.8bn doses of prospective Covid-19 vaccines in a “frenzy of deals” that could mean many poor countries would not get access to immunisation until at least 2024, a report says.
None of the 320-plus potential vaccines in development have been approved for use, but countries have already struck advance purchasing agreements for 3.73bn doses of the most promising candidates, with negotiations underway for another 5bn doses, the study by Duke University’s global health innovation centre calculated.
